- Home
- OCS vs WD Comparison
OCS vs WD Comparison
Compare OCS & WD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OCS | WD |
|---|---|---|
| Founded | 2003 | 1937 |
| Country | Switzerland | United States |
| Employees | 60 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | OCS | WD |
|---|---|---|
| Price | $11.76 | $51.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $42.00 | ★ $76.00 |
| AVG Volume (30 Days) | ★ 938.4K | 313.5K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 5.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.46 |
| Revenue | N/A | ★ $1,234,306,000.00 |
| Revenue This Year | $466.06 | $20.60 |
| Revenue Next Year | $479.73 | $7.79 |
| P/E Ratio | ★ N/A | $105.04 |
| Revenue Growth | N/A | ★ 8.99 |
| 52 Week Low | $11.70 | $42.12 |
| 52 Week High | $34.48 | $90.00 |
Technical Indicators
Market Signals| Indicator | OCS | WD |
|---|---|---|
| Relative Strength Index (RSI) | 21.61 | 52.73 |
| Support Level | N/A | $47.98 |
| Resistance Level | $21.00 | $52.44 |
| Average True Range (ATR) | 2.26 | 1.88 |
| MACD | -2.18 | -0.22 |
| Stochastic Oscillator | 2.10 | 73.28 |
Price Performance
Historical ComparisonAbout OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
About WD Walker & Dunlop Inc
Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of its total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.